Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Petitou

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Thrombosis Research|July 15, 1986
Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis modelJ M Walenga, J Fareed, M Petitou, et al.
The Journal of Biological Chemistry|March 18, 2000
The effect of a reducing-end extension on pentasaccharide binding by antithrombinK J Belzar, T R Dafforn, M Petitou, et al.
Thrombosis Research|May 15, 1997
The synthetic pentasaccharide SR 90107A/Org 31540 does not release lipase activity into the plasmaP Hoffmann, A Bernat, A Dumas, et al.
The Journal of Biological Chemistry|June 25, 1988
Is there a unique sequence in heparin for interaction with heparin cofactor II? Structural and biological studies of heparin-derived oligosaccharidesM Petitou, J C Lormeau, B Perly, et al.
Carbohydrate Research|April 1, 1987
Structural characterization of sulfated glycosaminoglycans by fast atom bombardment mass spectrometry: application to heparin fragments prepared by chemical synthesisV N Reinhold, S A Carr, B N Green, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
The anticoagulant activation of antithrombin by heparinL Jin, J P Abrahams, R Skinner, et al.
Thrombosis Research|April 15, 1987
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challengesJ M Walenga, M Petitou, J C Lormeau, et al.
Carbohydrate Research|March 15, 1986
Synthesis of heparin fragments. A chemical synthesis of the pentasaccharide O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1-4 )-O-(beta-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glu copyranosyl)-(1-4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1-4)-2-deoxy-2-sulfamido-6-O-sulfo-D-glucopyranose decasodium salt, a heparin fragment having high affinity for antithrombin IIIM Petitou, P Duchaussoy, I Lederman, et al.
Carbohydrate Research|September 15, 1987
Synthesis of heparin fragments: a methyl alpha-pentaoside with high affinity for antithrombin IIIM Petitou, P Duchaussoy, I Lederman, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
New synthetic heparin mimetics able to inhibit thrombin and factor XaM Petitou, P Duchaussoy, P A Driguez, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Thrombosis Research|July 15, 1986
Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis modelJ M Walenga, J Fareed, M Petitou, et al.
The Journal of Biological Chemistry|March 18, 2000
The effect of a reducing-end extension on pentasaccharide binding by antithrombinK J Belzar, T R Dafforn, M Petitou, et al.
Thrombosis Research|May 15, 1997
The synthetic pentasaccharide SR 90107A/Org 31540 does not release lipase activity into the plasmaP Hoffmann, A Bernat, A Dumas, et al.
The Journal of Biological Chemistry|June 25, 1988
Is there a unique sequence in heparin for interaction with heparin cofactor II? Structural and biological studies of heparin-derived oligosaccharidesM Petitou, J C Lormeau, B Perly, et al.
Carbohydrate Research|April 1, 1987
Structural characterization of sulfated glycosaminoglycans by fast atom bombardment mass spectrometry: application to heparin fragments prepared by chemical synthesisV N Reinhold, S A Carr, B N Green, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
The anticoagulant activation of antithrombin by heparinL Jin, J P Abrahams, R Skinner, et al.
Thrombosis Research|April 15, 1987
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challengesJ M Walenga, M Petitou, J C Lormeau, et al.
Carbohydrate Research|March 15, 1986
Synthesis of heparin fragments. A chemical synthesis of the pentasaccharide O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1-4 )-O-(beta-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glu copyranosyl)-(1-4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1-4)-2-deoxy-2-sulfamido-6-O-sulfo-D-glucopyranose decasodium salt, a heparin fragment having high affinity for antithrombin IIIM Petitou, P Duchaussoy, I Lederman, et al.
Carbohydrate Research|September 15, 1987
Synthesis of heparin fragments: a methyl alpha-pentaoside with high affinity for antithrombin IIIM Petitou, P Duchaussoy, I Lederman, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
New synthetic heparin mimetics able to inhibit thrombin and factor XaM Petitou, P Duchaussoy, P A Driguez, et al.
Pageof 12